Detalhe da pesquisa
1.
A CXCR4-targeted nanocarrier achieves highly selective tumor uptake in diffuse large B-cell lymphoma mouse models.
Haematologica
; 105(3): 741-753, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248974
2.
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors.
Acta Pharm Sin B
; 12(5): 2578-2591, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35646535
3.
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.
Pharmaceutics
; 14(4)2022 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456719
4.
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
J Exp Clin Cancer Res
; 41(1): 49, 2022 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120582
5.
Protein-driven nanomedicines in oncotherapy.
Curr Opin Pharmacol
; 47: 1-7, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30685732
6.
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
Head Neck
; 41(2): 429-439, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30548470
7.
The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
Head Neck
; 41(6): 1830-1845, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652380
8.
uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy.
Oncotarget
; 7(35): 57351-57366, 2016 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27385000
9.
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.
Head Neck
; 38 Suppl 1: E1392-403, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516695
10.
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Oncotarget
; 6(30): 29016-33, 2015 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359694
11.
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.
Cancer Med
; 2(6): 950-63, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24403269